MY8100025A - Vinca alkaloid derivatives - Google Patents

Vinca alkaloid derivatives

Info

Publication number
MY8100025A
MY8100025A MY25/81A MY8100025A MY8100025A MY 8100025 A MY8100025 A MY 8100025A MY 25/81 A MY25/81 A MY 25/81A MY 8100025 A MY8100025 A MY 8100025A MY 8100025 A MY8100025 A MY 8100025A
Authority
MY
Malaysia
Prior art keywords
vinca alkaloid
alkaloid derivatives
derivatives
vinca
alkaloid
Prior art date
Application number
MY25/81A
Other languages
English (en)
Inventor
George Joseph Cullinan
Kdert Gerzon
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MY8100025A publication Critical patent/MY8100025A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MY25/81A 1973-04-02 1981-12-30 Vinca alkaloid derivatives MY8100025A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34727573A 1973-04-02 1973-04-02

Publications (1)

Publication Number Publication Date
MY8100025A true MY8100025A (en) 1981-12-31

Family

ID=23363051

Family Applications (1)

Application Number Title Priority Date Filing Date
MY25/81A MY8100025A (en) 1973-04-02 1981-12-30 Vinca alkaloid derivatives

Country Status (28)

Country Link
JP (2) JPS5919117B2 (de)
AR (2) AR204004A1 (de)
AT (1) AT340605B (de)
BE (1) BE813168A (de)
BG (3) BG21612A3 (de)
CA (1) CA1042428A (de)
CH (1) CH603669A5 (de)
CS (1) CS185223B2 (de)
CY (1) CY1044A (de)
DD (1) DD113538A5 (de)
DE (1) DE2415980A1 (de)
DK (1) DK141511B (de)
ES (2) ES424882A1 (de)
FR (1) FR2223044B1 (de)
GB (1) GB1463575A (de)
HK (1) HK20180A (de)
HU (1) HU171572B (de)
IE (1) IE39071B1 (de)
IL (1) IL44415A (de)
KE (1) KE3028A (de)
MY (1) MY8100025A (de)
NL (1) NL181079C (de)
PH (1) PH13623A (de)
RO (2) RO73524B (de)
SE (1) SE416206B (de)
SU (4) SU731900A3 (de)
YU (3) YU39719B (de)
ZA (1) ZA741674B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48685A (en) * 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
GR69783B (de) * 1976-09-08 1982-07-07 Lilly Co Eli
US4096148A (en) * 1976-12-06 1978-06-20 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
USRE30560E (en) * 1976-12-06 1981-03-31 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
USRE30561E (en) 1976-12-06 1981-03-31 Eli Lilly And Company Vinca alkaloid intermediates
US4203898A (en) 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4199504A (en) * 1978-05-15 1980-04-22 Eli Lilly And Company Bridged cathranthus alkaloid dimers
US4357334A (en) 1980-03-20 1982-11-02 Eli Lilly And Company Use of VLB 3-(2-chloroethyl) carboxamide in treating neoplasms
OA06421A (fr) * 1980-06-10 1981-09-30 Omnium Chimique Sa Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.
LU83822A1 (fr) * 1981-12-08 1983-09-01 Omnichem Sa Derives n-(vinblastinoyl-23)d'acides amines,leur preparation et leur application therapeutique
FR2623504B1 (fr) * 1987-11-25 1990-03-09 Adir Nouveaux derives n-(vinblastinoyl-23) d'acide amino-1 methylphosphonique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
HUT76925A (hu) * 1995-04-04 1998-01-28 MTA Enzimológiai Intézet Bisz-indol-származékok, eljárás előállításukra és az azokat tartalmazó gyógyszerkészítmények
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6326402B1 (en) 1998-08-12 2001-12-04 Octamer, Inc. Methods for treating viral infections using a compound capable of inhibiting microtubules
AU2006207321B2 (en) 2005-01-21 2012-09-06 Astex Therapeutics Limited Pharmaceutical compounds
KR20080035630A (ko) 2005-07-18 2008-04-23 바이파 사이언스 인코포레이티드 암의 치료
US8143447B2 (en) 2006-09-05 2012-03-27 Bipar Sciences, Inc. Treatment of cancer
EP2061479A4 (de) 2006-09-05 2010-08-04 Bipar Sciences Inc Fettsäuresynthesehemmung durch parp-hemmer und behandlungsverfahren damit
JP5528807B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
KR20100102609A (ko) 2007-11-12 2010-09-24 바이파 사이언스 인코포레이티드 Ｐａｒｐ 억제제를 단독으로 사용하거나 항종양제와 병용하여 유방암을 치료하는 방법
JP6250710B2 (ja) * 2013-04-19 2017-12-20 曁南大学 ビンブラスチン誘導体の調製方法
CN113456797B (zh) * 2021-06-18 2024-03-08 暨南大学 长春碱类衍生物在制备治疗骨肉瘤和/或软组织肉瘤药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine

Also Published As

Publication number Publication date
BG21235A3 (de) 1976-03-20
IE39071B1 (en) 1978-08-02
BE813168A (fr) 1974-10-02
KE3028A (en) 1980-03-28
RO77533A (ro) 1982-02-01
GB1463575A (en) 1977-02-02
SU731900A3 (ru) 1980-04-30
RO73524B (ro) 1984-11-30
BG22831A3 (de) 1977-04-20
JPS49128000A (de) 1974-12-07
CS185223B2 (en) 1978-09-15
DK141511C (de) 1980-09-29
DK141511B (da) 1980-04-08
DE2415980C2 (de) 1989-11-09
DE2415980A1 (de) 1974-10-10
JPS59193895A (ja) 1984-11-02
CY1044A (en) 1980-08-01
YU113880A (en) 1982-05-31
ES446571A1 (es) 1977-06-16
SE416206B (sv) 1980-12-08
ZA741674B (en) 1975-10-29
SU784783A3 (ru) 1980-11-30
ATA267974A (de) 1977-04-15
DD113538A5 (de) 1975-06-12
YU81774A (en) 1982-05-31
HK20180A (en) 1980-04-25
AU6671974A (en) 1975-09-18
YU39719B (en) 1985-04-30
SU623522A3 (ru) 1978-09-05
NL181079C (nl) 1987-06-16
NL7404423A (de) 1974-10-04
NL181079B (nl) 1987-01-16
CH603669A5 (de) 1978-08-31
YU39876B (en) 1985-04-30
JPS6033837B2 (ja) 1985-08-05
IL44415A0 (en) 1974-06-30
JPS5919117B2 (ja) 1984-05-02
AR203882A1 (es) 1975-10-31
RO73524A (ro) 1984-10-31
CA1042428A (en) 1978-11-14
AR204004A1 (es) 1975-11-12
HU171572B (hu) 1978-02-28
ES424882A1 (es) 1976-12-16
PH13623A (en) 1980-08-07
FR2223044B1 (de) 1978-06-30
SU652896A3 (ru) 1979-03-15
BG21612A3 (de) 1976-07-20
AT340605B (de) 1977-12-27
FR2223044A1 (de) 1974-10-25
IL44415A (en) 1978-08-31
YU113980A (en) 1982-05-31
YU39875B (en) 1985-04-30
IE39071L (en) 1974-10-02

Similar Documents

Publication Publication Date Title
HK15781A (en) Cephalosporin derivatives
MY8100025A (en) Vinca alkaloid derivatives
ZA743760B (en) Xanthine derivatives
KE2946A (en) Pyrazino-isoquinoline derivatives
GB1484242A (en) Penicillin derivatives
IL45505A0 (en) Cephalosporin derivatives
HK53980A (en) Vincamine derivatives
GB1483352A (en) Phenyl-alkenol and-alkanol derivatives
IL43704A0 (en) Lactamimide derivatives
ZA744175B (en) Cephalosporin derivatives
IL45693A0 (en) Cephalosporin derivatives
PH12303A (en) Thienotriazolodiazepine derivatives
HK181A (en) Benzylpyrimidine derivatives
HK54080A (en) Dihydroergopeptine derivatives
IL45692A0 (en) Cephalosporin derivatives
GB1483621A (en) Rifamycin derivatives
ZA741498B (en) Imidazo heterocyclic derivatives
ZA74675B (en) Ergoline derivatives
IL44831A0 (en) Pyrazinoisoquinoline derivatives
GB1408550A (en) Gitoxigenin-digitoxoside derivatives
AU7333774A (en) Arylchalcogeno-hydrocarbon derivatives
AU7333674A (en) Arylchalcogeno-hydrocarbon derivatives
ZA747137B (en) Penicillin derivatives
IL41634A0 (en) Penicillin derivatives
GB1407193A (en) Thiaisochromane derivatives